Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
AAPS Pharmscitech|August 1, 2018
Morphological, Stability, and Hypoglycemic Effects of New Gliclazide-Bile Acid Microcapsules for Type 1 Diabetes Treatment: the Microencapsulation of Anti-diabetics Using a Microcapsule-Stabilizing Bile AcidSangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso, et al.
Drug Delivery|November 27, 2015
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetesSangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso, et al.
Artificial Cells, Nanomedicine, and Biotechnology|July 28, 2015
The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetesSangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso, et al.
Drug Design, Development and Therapy|October 11, 2014
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancerArmin Mooranian, Rebecca Negrulj, Nigel Chen-Tan, et al.
Artificial Cells, Nanomedicine, and Biotechnology|October 31, 2014
Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatmentArmin Mooranian, Rebecca Negrulj, Nigel Chen-Tan, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 19, 2016
In Vitro Antimicrobial Efficacy of Tobramycin Against Staphylococcus aureus Biofilms in Combination With or Without DNase I and/or Dispersin B: A Preliminary InvestigationCharlene Babra Waryah, Kelsi Wells, Dulantha Ulluwishewa, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 27, 2015
Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetesRebecca Negrulj, Armin Mooranian, Nigel Chen-Tan, et al.
Chemical Communications (Cambridge, England)|March 7, 2019
Molten metal closo-borate solvatesKasper T Møller, Mark Paskevicius, Jacob G Andreasen, et al.
Drug Design, Development and Therapy|August 13, 2014
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization studyArmin Mooranian, Rebecca Negrulj, Nigel Chen-Tan, et al.
Journal of Pharmaceutical Innovation|May 16, 2014
Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of AntidiabeticsArmin Mooranian, Rebecca Negrulj, Sangeetha Mathavan, et al.
Pageof 2